Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
Links relacionados
- Similares em SciELO
Compartilhar
Acta Médica Peruana
versão On-line ISSN 1728-5917
Resumo
RECABARREN LOZADA, Arturo Felipe; LLANOS ROSAS, Marcos Gustavo e LLAVE PINTO, Gustavo Joel. Clinical comparison in the remote management of bronchial asthma during the COVID-19 pandemic between two controller therapies: Fluticasone and beclomethasone. Acta méd. Peru [online]. 2023, vol.40, n.4, pp.300-307. Epub 31-Dez-2023. ISSN 1728-5917. http://dx.doi.org/10.35663/amp.2023.404.2692.
Objective:
To compare the level of asthma control using the Asthma Control Test (ACT) and clinical manifestations in two groups of patients treated with different inhaled corticosteroids (ICG): fluticasone and beclometasone.
Materials and methods:
An observational, comparative and prospective study was conducted in 521 children in the asthma program of Hospital III Yanahuara. During the period from June 2020 to December 2021, the level of asthma control was assessed by remote consultations using ACT and collection of clinical findings. Patients were grouped according to the type of ICG they were using. Data were recorded at two different time points for each patient, with a 4-month interval between each control, during the COVID-19 pandemic and the level of control was compared by ACT score and clinical manifestations between the two groups of patients at both time points of the study.
Results:
Both groups had optimal control at baseline and at the end of the study. In clinical manifestations there was no statistical difference (P > 0.05) in favor of either drug in either control. However, in the second control (discharge) a significant difference was found for fluticasone versus beclometasone (P = 0.030).
Conclusions:
Fluticasone was found to have superiority in the level of asthma control over beclomethasone. However, the determining factor in achieving good control is the continuous use of any IGC.
Palavras-chave : Asthma; COVID-19; Glucocorticoids; Remote Consultation; Fluticasone; Beclomethasone.